RIPK3 and cancer: Related to the mechanism of action, our results show that CV extract induce RIPK1/RIPK3/MLKL-dependent necroptosis, in the depigmented melanoma cells, which serves as an alternative mode of programmed cell death to eradicate apoptosis-resistant cancer cells.